SYNDAX PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.06 USD | +2.38% |
|
+1.25% | -2.55% |
Chart calendar Syndax Pharmaceuticals, Inc.
8f8dd40dd1ba2.rJ2g6zmMCelhvJUQFNoIiToi0Sw3fty5LboIOlVqsM8.y8vNoWH9PYI17KN-VZ878Whol0JhK5ndHo9ucGEn0_349PiFV-VmuhnKzA~4b03e01ccbc1775716cf371a2a67a382
Upcoming events on Syndax Pharmaceuticals, Inc.
Past events on Syndax Pharmaceuticals, Inc.
| 17/04/2024 16:00 | Stifel Virtual Targeted Oncology Days Conference |
| 02/04/2024 | American Society of Pediatric Hematology/Oncology Conference |
| 12/03/2024 12:30 | Barclays Global Healthcare Conference |
| 04/03/2024 17:50 | TD Cowen Health Care Conference - Panel |
| 04/03/2024 14:50 | TD Cowen Health Care Conference |
| 27/02/2024 21:30 | Q4 2023 Earnings Call |
| 27/02/2024 21:05 | Q4 2023 Earnings Release |
| 21/02/2024 19:00 | Citi Oncology Leadership Summit |
| 08/02/2024 15:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 18/01/2024 18:30 | B. Riley Securities Oncology Conference - Track 1 |
| 09/01/2024 01:15 | JPMorgan Healthcare Conference |
| 12/12/2023 18:00 | American Society of Hematology Meeting - Abstract Number: LBA-5 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 4950 |
| 11/12/2023 15:00 | American Society of Hematology Meeting |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number: 2540 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 2907 |
| 10/12/2023 | American Society of Hematology Meeting |
| 10/12/2023 22:00 | American Society of Hematology Meeting - Abstract Number: 1 |
| 09/12/2023 | American Society of Hematology Meeting |
| 09/12/2023 18:15 | American Society of Hematology Meeting - Abstract Number : 58 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,52 1,50 1.29% | 1,52 1,47 3.54% | 140 81,4 71.65% | 0,00 0,33 - | 0,00 0,00 - | 31,0 |
|
EBITDA Million USD | Released Forecast Spread | -58,2 -57,5 -1.3% | -71,3 -71,7 0.51% | 26,9 34,3 -21.62% | -155 -149 -3.75% | -245 -233 -5.05% | -357 |
|
EBIT Million USD | Released Forecast Spread | -57,5 -57,8 0.54% | -71,4 -72,5 1.48% | 26,2 -21,7 220.66% | -152 -150 -1.33% | -230 -226 -1.93% | -335 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,0 -56,1 0.18% | -73,2 -75,2 2.68% | 24,9 -72,7 134.3% | -149 -150 0.12% | -209 -207 -1.33% | -325 |
|
Net income Million USD | Released Forecast Spread | -56,0 -56,3 0.39% | -77,1 -77,5 0.58% | 24,9 -72,7 134.3% | -149 -150 0.36% | -209 -208 -0.58% | -314 |
|
EPS USD | Released Forecast Spread | -1,84 -1,87 1.39% | -1,87 -1,81 -3.54% | 0,48 -1,41 134.16% | -2,46 -2,48 0.62% | -2,98 -2,94 -1.5% | -3,76 |
| Announcement Date | 03/03/20 | 08/03/21 | 01/03/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 127 58,7 115.72% | 0,00 2,56 - | 0,00 1,10 - | 0,00 0,60 - | 0,00 0,43 - | 0,00 0,50 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 6,37 | 25,1 |
|
EBITDA Million USD | Released Forecast Spread | -81,4 -73,5 -10.71% | -75,6 | -77,7 | -80,0 | |||||||||
|
EBIT Million USD | Released Forecast Spread | 95,7 39,5 142.67% | -36,9 -34,8 -6.03% | -37,7 -36,5 -3.32% | -35,1 -37,7 6.77% | -42,0 -39,6 -6.14% | -46,0 -43,1 -6.83% | -49,7 -54,3 8.47% | -56,4 -59,0 4.52% | -77,9 -73,5 -6.02% | -84,1 | -88,5 | -86,5 | -73,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 96,2 -1,21 8037.13% | -37,2 -37,6 1.19% | -37,6 -38,7 3% | -35,4 -38,7 8.44% | -39,2 -39,9 1.75% | -41,1 -39,8 -3.3% | -44,6 -52,9 15.66% | -51,1 -55,0 7.07% | -72,5 -69,8 -3.77% | -80,3 | -84,4 | -80,5 | -77,9 |
|
Net income Million USD | Released Forecast Spread | 96,2 -1,21 8037.13% | -37,2 -36,7 -1.2% | -37,6 -38,9 3.45% | -35,4 -38,7 8.48% | -39,2 -41,1 4.59% | -41,1 -40,4 -1.91% | -44,6 -50,8 12.17% | -51,1 -55,9 8.44% | -72,5 -71,5 -1.36% | -79,6 | -83,8 | -81,2 | -66,9 |
|
EPS USD | Released Forecast Spread | 1,81 -0,03 6133.33% | -0,63 -0,64 1.56% | -0,62 -0,66 5.7% | -0,58 -0,65 10.08% | -0,62 -0,66 5.82% | -0,59 -0,60 1.01% | -0,64 -0,73 12.03% | -0,73 -0,80 8.62% | -1,00 -0,96 -4.41% | -0,97 | -1,03 | -0,98 | -0,80 |
| Announcement Date | 01/03/22 | 09/05/22 | 08/08/22 | 03/11/22 | 28/02/23 | 08/05/23 | 03/08/23 | 02/11/23 | 27/02/24 | - | - | - | - |
More events
Past sector events for Syndax Pharmaceuticals, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNDX Stock
- Calendar Syndax Pharmaceuticals, Inc.
